Premium
Heterotypic and homotypic cell‐cell adhesion molecules in endothelial cells
Author(s) -
Kalra VK,
Banerjee R.,
Sorgente N.
Publication year - 1990
Publication title -
biotechnology and applied biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.468
H-Index - 70
eISSN - 1470-8744
pISSN - 0885-4513
DOI - 10.1111/j.1470-8744.1990.tb00132.x
Subject(s) - endothelial stem cell , monoclonal antibody , antibody , microbiology and biotechnology , biology , antigen , cell adhesion , cell adhesion molecule , receptor , cell , chemistry , immunology , biochemistry , in vitro
Sickle red blood cells display an abnormal propensity to adhere to cultured bovine aortic endothelial cells when compared to normal red blood cells. The adherence was potentiated three‐fold by endothelial cell derived conditioned medium, enriched in multimers of von Willebrand factor. Such adherence was ablated by 80% by either the synthetic peptide (RGDS) or antibody to GPIIb/IIIa, indicating the presence of RGD peptide recognition domain/receptor in either endothelial cells or sickle cells or both. The adherence was also inhibited by 70% by phosphatidylserine, but not by other phospholipids, indicating the presence of putative receptors for this phospholipid in endothelial cells. The labeling of cultured bovine aortic endothelial cells with monoclonal antibodies revealed the localization of MAB D2 to regions of cell‐cell contact. The antigen on endothelial cells which cross‐reacts with this antibody has a Mr of 130,000. The addition of such an antibody during the plating of endothelial cells disrupted monolayer formation. It appears that a 130‐kDa polypeptide antigen in endothelial cells which is recognized by MAB D2, may be a cell‐cell adhesion molecule.